<DOC>
	<DOCNO>NCT01984164</DOCNO>
	<brief_summary>The aim study conduct 1-year double blind randomize control trial compare candesartan lisinopril 140 individual hypertension executive mild cognitive impairment effect executive function , neuroimaging marker , vascular indicator .</brief_summary>
	<brief_title>CAndesartan v LIsinopril Effects BRain</brief_title>
	<detailed_description>- Hypertension associate cognitive impairment even absence clinical dementia . To date , specific treatment available pattern mild cognitive impairment relate hypertension . - Objectives purpose : The aim study investigate effect candesartan executive function decline change cerebral perfusion , cerebrovascular reserve microvascular brain injury . The study also intend identify potential underlie mechanism related vascular structure function , include atherosclerosis , vascular inflammation , vascular stiffness , endothelial progenitor cell , candesartan may affect cognitive cerebrovascular outcome . - Study methodology : This double blind randomize clinical trial conduct 140 individual ( 70 candesartan group , 70 lisinopril group ) . Our target population subject : 60 year old hypertension Executive Mild Cognitive Impairment . - Endpoints measure : Our measure include cognitive function , cerebral perfusion reserve , marker vascular brain damage , atherosclerosis , stiffness , vascular inflammation endothelial function . - Description intervention , follow-up , duration study : Eligible participant undergo randomization 2 group see frequently blood pressure control ( &lt; 140/90 mmHg ) . Participants see 3 , 6 12 month afterwards .</detailed_description>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Mild Cognitive Impairment</mesh_term>
	<mesh_term>Lisinopril</mesh_term>
	<mesh_term>Candesartan</mesh_term>
	<mesh_term>Candesartan cilexetil</mesh_term>
	<mesh_term>Metoprolol</mesh_term>
	<criteria>1. age : 55 year old ; 2 . Hypertension : SBP≥140 mm Hg DBP≥ 90 mm receive antihypertensive medication . 3 . Executive MCI define use criterion : 1 . The Montreal Cognitive Assessment ( MoCA ) score less 26 2 . Clinical Dementia Rating ( CDR ) score 0.5 , 3 . Executive dysfunction : A performance 10th percentile least one four screening test executive function : Trail Making Test , Part B ( TMTB ) , modify Stroop interference , verbal fluency ( number D word 1 minute ) , abstraction . 1 . Intolerance study drug ; 2 . SBP &gt; 200 DBP &gt; 110 mm Hg ; 3 . Renal disease hyperkalemia 4 . Active medical psychiatric problem 5 . Uncontrolled congestive heart failure ; 6 . History stroke past 3 year ; 7 . Inability perform study procedures 8 . Women childbearing potential 9. diagnosis dementia</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>cerebrovascular function</keyword>
</DOC>